Abstract
Endometriosis is a chronic disease primarily affecting women of childbearing age, typically leading to painful symptoms, fatigue, and infertility. Quality of life studies show that symptoms of endometriosis impact on many aspects of a woman’s life, including work and education, relationships, and social functioning.(1) Dienogest is a progestin investigated for the treatment of endometriosis in several clinical studies in Europe and Japan. (2) The aim of this study is to assess the safety and efficacy of dienogest 2mg/day for long-term treatment of endometriosis associated pain, and to evaluate adverse effects and improvement in quality life for long-term endometriosis treatment.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call